Fulgent Genetics (FLGT) Earnings Analysis

Fulgent Genetics (FLGT) next reports earnings on 2026-07-30, consensus EPS -0.46 USD. Last quarter (2026-05-01) it missed with EPS -0.36 USD vs -0.34815 USD est (-3.4%). It has beaten estimates in 7/8 recent quarters (88%). Trailing P/E -8.21.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does FLGT next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate-0.46 USD
Revenue estimate0.09B

FLGT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-01-0.36 USD-0.34815 USD-3.4%Miss
2026-02-270.16 USD0.03 USD+433.3%Beat
2025-11-070.14 USD-0.24 USD+158.3%Beat
2025-08-010.07 USD-0.23 USD+130.4%Beat
2025-05-020.04 USD-0.19 USD+121.1%Beat
2025-02-280.04 USD-0.31 USD+112.9%Beat
2024-11-080.31 USD-0.19 USD+263.2%Beat
2024-08-020.15 USD-0.31 USD+148.4%Beat

Beat rate: 7/8 (88%) over reported quarters with consensus data.

FLGT valuation and analyst view

Trailing P/E-8.21
Trailing EPS-2.39011 USD
Price / book0.57
Dividend yield0.00%
Market cap0.56B
Analyst consensusBuy (6 buy / 3 hold / 0 sell)
Avg price target15 USD

Related research pages

Frequently asked questions

When is Fulgent Genetics (FLGT)'s next earnings date?

Fulgent Genetics is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -0.46 USD and revenue estimate of 0.09B.

Did FLGT beat earnings last quarter?

In its 2026-05-01 report, FLGT posted EPS of -0.36 USD versus a -0.34815 USD estimate — a miss of 3.4%.

What is FLGT's earnings track record?

Over the last 8 reported quarters with consensus data, FLGT beat estimates 7 times (88%).

What is FLGT's current P/E ratio and EPS?

FLGT trades at a trailing P/E of -8.21 on trailing EPS of -2.390110423885237 USD.

What do analysts rate FLGT?

Analyst consensus is "Buy" across 9 ratings (0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 15 USD.